1.
Clin Oncol (R Coll Radiol)
; 22(2): 131-5, 2010 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19969444
RESUMEN
Patients with good prognosis differentiated thyroid cancer are at risk from over-treatment with radioiodine thyroid remnant ablation. Some with unfavourable localised disease might benefit from an elective second dose.